Kamada (KMDA) Share-based Compensation Growth (3y) (2015 - 2026)
Kamada (KMDA) Share-based Compensation Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Kamada | 462.32 Mn | 432.85 Mn | 22.47 Mn | 49.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,144.55% |
| Dec 31, 2025 | 141.24% |
| Sep 30, 2025 | 583.76% |
| Jun 30, 2025 | -36.78% |
| Mar 31, 2025 | -3.21% |
| Dec 31, 2024 | 22.88% |
| Sep 30, 2024 | 18.68% |
| Jun 30, 2024 | 14.88% |
| Mar 31, 2024 | 3.88% |
| Dec 31, 2023 | 178.06% |
| Sep 30, 2023 | 5.59% |
| Jun 30, 2023 | -9.32% |
| Mar 31, 2023 | -88.27% |
| Dec 31, 2022 | -47.82% |
| Sep 30, 2022 | -90.57% |
| Jun 30, 2022 | 47.57% |
| Mar 31, 2022 | -15.07% |
| Dec 31, 2021 | -34.38% |
| Sep 30, 2021 | -23.04% |
| Jun 30, 2021 | -5.56% |